Sage Therapeutic Stock Market Value
| SAGE Stock | USD 13.04 0.47 3.74% |
| Symbol | Sage |
Is Sage Therapeutic's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sage Therapeutic. If investors know Sage will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sage Therapeutic listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Sage Therapeutic is measured differently than its book value, which is the value of Sage that is recorded on the company's balance sheet. Investors also form their own opinion of Sage Therapeutic's value that differs from its market value or its book value, called intrinsic value, which is Sage Therapeutic's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sage Therapeutic's market value can be influenced by many factors that don't directly affect Sage Therapeutic's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sage Therapeutic's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sage Therapeutic is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sage Therapeutic's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Sage Therapeutic 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Sage Therapeutic's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Sage Therapeutic.
| 03/20/2024 |
| 04/19/2024 |
If you would invest 0.00 in Sage Therapeutic on March 20, 2024 and sell it all today you would earn a total of 0.00 from holding Sage Therapeutic or generate 0.0% return on investment in Sage Therapeutic over 30 days. Sage Therapeutic is related to or competes with Apellis Pharmaceuticals, Terns Pharmaceuticals, Day One, Blueprint Medicines, Cerevel Therapeutics, Amylyx Pharmaceuticals, and Relay TherapeuticsInc. Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous sys... More
Sage Therapeutic Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Sage Therapeutic's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Sage Therapeutic upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.29) | |||
| Maximum Drawdown | 31.44 | |||
| Value At Risk | (4.75) | |||
| Potential Upside | 2.82 |
Sage Therapeutic Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Sage Therapeutic's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Sage Therapeutic's standard deviation. In reality, there are many statistical measures that can use Sage Therapeutic historical prices to predict the future Sage Therapeutic's volatility.| Risk Adjusted Performance | (0.16) | |||
| Jensen Alpha | (0.99) | |||
| Total Risk Alpha | (1.40) | |||
| Treynor Ratio | 1.25 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Sage Therapeutic's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Sage Therapeutic Backtested Returns
Sage Therapeutic owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.27, which indicates the firm had a -0.27% return per unit of risk over the last 3 months. Sage Therapeutic exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Sage Therapeutic's Variance of 14.21, risk adjusted performance of (0.16), and Coefficient Of Variation of (365.31) to confirm the risk estimate we provide. The entity has a beta of -0.84, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Sage Therapeutic are expected to decrease at a much lower rate. During the bear market, Sage Therapeutic is likely to outperform the market. Sage Therapeutic has an expected return of -1.03%. Please make sure to validate Sage Therapeutic treynor ratio, accumulation distribution, price action indicator, as well as the relationship between the potential upside and day median price , to decide if Sage Therapeutic performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.82 |
Very good predictability
Sage Therapeutic has very good predictability. Overlapping area represents the amount of predictability between Sage Therapeutic time series from 20th of March 2024 to 4th of April 2024 and 4th of April 2024 to 19th of April 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Sage Therapeutic price movement. The serial correlation of 0.82 indicates that around 82.0% of current Sage Therapeutic price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.82 | |
| Spearman Rank Test | 0.81 | |
| Residual Average | 0.0 | |
| Price Variance | 1.91 |
Sage Therapeutic lagged returns against current returns
Autocorrelation, which is Sage Therapeutic stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Sage Therapeutic's stock expected returns. We can calculate the autocorrelation of Sage Therapeutic returns to help us make a trade decision. For example, suppose you find that Sage Therapeutic has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Sage Therapeutic regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Sage Therapeutic stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Sage Therapeutic stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Sage Therapeutic stock over time.
Current vs Lagged Prices |
| Timeline |
Sage Therapeutic Lagged Returns
When evaluating Sage Therapeutic's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Sage Therapeutic stock have on its future price. Sage Therapeutic autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Sage Therapeutic autocorrelation shows the relationship between Sage Therapeutic stock current value and its past values and can show if there is a momentum factor associated with investing in Sage Therapeutic.
Regressed Prices |
| Timeline |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Sage Therapeutic in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Sage Therapeutic's short interest history, or implied volatility extrapolated from Sage Therapeutic options trading.
Currently Active Assets on Macroaxis
When determining whether Sage Therapeutic is a strong investment it is important to analyze Sage Therapeutic's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Sage Therapeutic's future performance. For an informed investment choice regarding Sage Stock, refer to the following important reports:Check out Sage Therapeutic Correlation, Sage Therapeutic Volatility and Sage Therapeutic Alpha and Beta module to complement your research on Sage Therapeutic. For information on how to trade Sage Stock refer to our How to Trade Sage Stock guide.Note that the Sage Therapeutic information on this page should be used as a complementary analysis to other Sage Therapeutic's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Complementary Tools for Sage Stock analysis
When running Sage Therapeutic's price analysis, check to measure Sage Therapeutic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sage Therapeutic is operating at the current time. Most of Sage Therapeutic's value examination focuses on studying past and present price action to predict the probability of Sage Therapeutic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sage Therapeutic's price. Additionally, you may evaluate how the addition of Sage Therapeutic to your portfolios can decrease your overall portfolio volatility.
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |
Sage Therapeutic technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.